Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

China Medical University Hospital is the lead sponsor of 70 current clinical trials in our China register. 46 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Nmdae, AIFA and B10 L-BPA. The most-studied condition is Schizophrenia.

ClinicalTrials.gov trials by status

Recruiting4666%
Not yet open913%
Active, closed811%
By invitation710%

Trials by phase

Not applicable3956%
Phase 21217%
Observational1217%
Phase 1/246%
Phase EARLY_PHASE111%
Phase 411%
Phase 111%

Clinical trials sponsored by China Medical University Hospital

70 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
ADSCs Therapy in Patients With CTD-ILD NCT06574581 · ClinicalTrials.gov ↗ · Connective Tissue Diseases, Interstitial Lung Disease	Phase 1/2	Recruiting	2024-08	China
Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers NCT06952868 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Boron Neutron Capture Therapy Drug: B10 L-BPA	Phase 2	Recruiting	2025-05	China
Assessing Clinical Impact of AI for Iron Deficiency NCT07394088 · ClinicalTrials.gov ↗ · Iron Deficiency, Iron Deficiency Anemias	Not applicable	Recruiting	2026-04	China
Comparison of Intr-operative Neuromonitoring Technique in Trans-oral Endoscopic Thyroidectomy Vestibular Approach NCT06801444 · ClinicalTrials.gov ↗ · Thyroidectomy	Observational	Recruiting	2023-03	China
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery NCT06104774 · ClinicalTrials.gov ↗ · Thoracic Neoplasms	Not applicable	Recruiting	2023-10	China
Digital Technology for Active and Healthy Ageing in Taiwan NCT07232667 · ClinicalTrials.gov ↗ · Healthy Aging, Digital Health Literacy	Observational	Recruiting	2026-04	China
Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics of Inflammatory Bowel Disease and Research on Metabolic Plastids of Tongue Coating NCT07314151 · ClinicalTrials.gov ↗ · Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)	Observational	Recruiting	2024-02	China
A Comparison Study for Unstable Sacrum/Pelvis and Acetabular Fracture Treated With Open Reduction and Internal Fixation With Minimally Invasive Internal Fixation NCT05683314 · ClinicalTrials.gov ↗ · Unstable Sacral/Pelvic or Acetabular Fracture	Observational	Recruiting	2018-01	China
Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's Disease During Different Ambulatory Complexities: An Electrophysiological and fMRI Study NCT06505460 · ClinicalTrials.gov ↗ · Transcranial Direct Current Stimulation	Not applicable	Recruiting	2024-04	China
Omega-3, Autism Spectrum Disorder (ASD) NCT07365553 · ClinicalTrials.gov ↗ · ASD	Not applicable	Recruiting	2022-07	China
The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon Monoxide Poisoning NCT06811675 · ClinicalTrials.gov ↗ · Carbon Monoxide Poisoning, Delayed Neurocognitive Sequelae	Phase 4	Recruiting	2025-03	China
The Effects of Dynamic Taping Combined With Corrective Exercises on Cervical Proprioception and Muscle Imbalance in Patients With Upper Crossed Syndrome NCT07182461 · ClinicalTrials.gov ↗ · Upper Crossed Syndrome	Not applicable	Recruiting	2025-03	China
Monotherapy of an NMDA Enhancer for Schizophrenia NCT04745143 · ClinicalTrials.gov ↗ · Schizophrenia	Phase 2	Recruiting	2018-01	China
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients NCT06452966 · ClinicalTrials.gov ↗ · Organ Failure, Multiple, Indigestion, Delayed Gastric Emptying	Not applicable	Recruiting	2024-05	China
NMDA Receptor Modulation for the Treatment of Bipolar I Disorder NCT05977023 · ClinicalTrials.gov ↗ · Bipolar I Disorder Drug: Nmdae	Phase 2	Recruiting	2023-10	China
Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy NCT07503496 · ClinicalTrials.gov ↗ · Breast Cancer Stages I, Breast Cancer Stages II, Breast Cancer Stage III	Not applicable	Recruiting	2025-04	China
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors NCT07003139 · ClinicalTrials.gov ↗ · Malignant Brain Tumors Drug: B10 L-BPA	Phase 1/2	Recruiting	2025-06	China
Evaluation of the JUICE HA® as an Anti-sarcopenia NCT06950125 · ClinicalTrials.gov ↗ · Sarcopenia in Elderly	Not applicable	Recruiting	2025-06	China
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer NCT05052853 · ClinicalTrials.gov ↗ · Prodromal Schizophrenia Drug: Nmdae	Phase 2	Recruiting	2021-11	China
NMDA Modulation in Major Depressive Disorder NCT04637620 · ClinicalTrials.gov ↗ · Major Depressive Disorder Drugs: Nmdae, Sertraline	Phase 2	Recruiting	2017-06	China
The Effects of Cosmetic Acupuncture NCT06952959 · ClinicalTrials.gov ↗ · Aging, Skin Health	Not applicable	Recruiting	2025-04	China
The Mobile-based Training System in Peritoneal Dialysis Patients NCT06876987 · ClinicalTrials.gov ↗ · Peritoneal Dialysis	Not applicable	Recruiting	2025-03	China
Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss NCT07235488 · ClinicalTrials.gov ↗ · Sudden Hearing Loss	Not applicable	Recruiting	2024-07	China
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia NCT04959201 · ClinicalTrials.gov ↗ · Schizophrenia Drug: Nmdae	Phase 2	Recruiting	2020-11	China
Knee-Hip-Spine Harmony: The Relationship Between Sagittal Spinal Alignment in Total Hip/Knee Arthroplasty NCT05685706 · ClinicalTrials.gov ↗ · Cases Who Received TKA/THA	Observational	Recruiting	2021-07	China
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression NCT07363551 · ClinicalTrials.gov ↗ · ADHD	Not applicable	Recruiting	2021-06	China
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia NCT06574360 · ClinicalTrials.gov ↗ · Schizophrenia Drug: Nmdae	Phase 2	Recruiting	2024-09	China
NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder NCT05136755 · ClinicalTrials.gov ↗ · Major Depressive Disorder Drug: Nmdae	Phase 2	Recruiting	2022-01	China
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients NCT06071013 · ClinicalTrials.gov ↗ · Non-small Cell Lung Cancer, EGFR Gene Mutation, EGFR-TKI Resistant Mutation	Phase 1/2	Recruiting	2024-02	China
Ultra-processed Food Consumption and Behavioral Disorder and Cognitive Function NCT07465081 · ClinicalTrials.gov ↗ · ADD/ADHD	Not applicable	Recruiting	2025-03	China
Imatinib and Trametinib for KRAS-mutated Solid Tumor NCT06962254 · ClinicalTrials.gov ↗ · Solid Tumor Cancer Drugs: Imatinib, Trametinib	Phase 1	Recruiting	2025-05	China
Sex Differences in NMDA-enhancing Treatment of Schizophrenia NCT07122895 · ClinicalTrials.gov ↗ · Schizophrenia Drug: Nmdae	Phase 2	Recruiting	2025-09	China
Feasibility of Wearables in Dementia Care in Rural Taiwan NCT07249918 · ClinicalTrials.gov ↗ · Alzheimer's Dementia, Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Wearable Devices	Not applicable	Recruiting	2025-11	China
The Clinical Research of Auricular Magnet for Anorexia in Children NCT06619548 · ClinicalTrials.gov ↗ · Anorexia in Children	Not applicable	Recruiting	2024-10	China
The Taiwan OSA Study NCT07302685 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea	Observational	Recruiting	2020-04	China
Effectiveness of an Acupressure Band for Primary Dysmenorrhea in College Students NCT07794995 · ClinicalTrials.gov ↗ · Primary Dysmenorrhea (PD)	Not applicable	Recruiting	2026-09	China
Full-Body and Lower-Limb Stretching on Explosive Power and Agility NCT07796464 · ClinicalTrials.gov ↗ · Static Stretching	Observational	Recruiting	2026-04	China
A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients NCT07136935 · ClinicalTrials.gov ↗ · Frail Elderly Patients	Not applicable	Recruiting	2025-07	China
The Roles of Human Microbiome and Vitamin D in the Development of Childhood Allergic Diseases NCT05670262 · ClinicalTrials.gov ↗ · Pediatric	Observational	Recruiting	2022-08	China
Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients NCT06711003 · ClinicalTrials.gov ↗ · Cerebrovascular Accident (CVA)	Not applicable	Recruiting	2024-10	China
Risk Factors for Developing Peak Plantar Pressure During Walking in the Diabetic Patients NCT07164495 · ClinicalTrials.gov ↗ · Diabete Type 2	Observational	Recruiting	2024-10	China
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia NCT05240976 · ClinicalTrials.gov ↗ · Schizophrenia Drugs: AIFA, Nmdae	Phase 2	Recruiting	2022-02	China
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia NCT04917302 · ClinicalTrials.gov ↗ · Schizophrenia Drugs: AIFA, Nmdae	Phase 2	Recruiting	2020-10	China
Acute Effects of Transcutaneous Electrical Nerve Stimulation at Acupoints on Nociceptive Transmission NCT07267052 · ClinicalTrials.gov ↗ · Pain Management	Not applicable	Recruiting	2025-09	China
Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD) NCT07364331 · ClinicalTrials.gov ↗ · ADHD, Children, Adolescents	Not applicable	Recruiting	2021-09	China
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia NCT06021197 · ClinicalTrials.gov ↗ · Schizophrenia Drug: Nmdae	Phase 2	Recruiting	2023-10	China
Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease NCT07657351 · ClinicalTrials.gov ↗ · Diabetic Kidney Disease	Not applicable	Not yet open	2026-06	China
Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD NCT07657338 · ClinicalTrials.gov ↗ · Non-diabetic Chronic Kidney Disease	Not applicable	Not yet open	2026-06	China
Laser Acupuncture for Behavioral and Psychological Symptoms of Dementia NCT07204145 · ClinicalTrials.gov ↗ · Behavioral and Psychological Symptoms of Dementia (BPSD), Dementia	Not applicable	Not yet open	2025-10	China
Individualized Acupoint Therapy for Dysmenorrhea: An Exploratory Research Design Based on Meridian Measurement NCT07818044 · ClinicalTrials.gov ↗ · Primary Dysmenorrhea (PD)	Not applicable	Not yet open	2026-09	China
Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa) NCT07560410 · ClinicalTrials.gov ↗ · Bone Cancer Drug: Alectinib	Phase 1/2	Not yet open	2026-05	China
CES and EGChatbot in Reducing Anxiety, Depression, Insomnia, and Mental Risk NCT06493695 · ClinicalTrials.gov ↗ · Depression, Anxiety	Not applicable	Not yet open	2024-09	China
Segmental Laser Acupuncture for Constipation and Sleep in Patients With Parkinson's Disease NCT07790094 · ClinicalTrials.gov ↗ · Parkinson's Disease	Not applicable	Not yet open	2026-09	China
Chinese Classics Recitation Training in Subjective Cognitive Decline NCT07463391 · ClinicalTrials.gov ↗ · Subjective Cognitive Decline (SCD), Subjective Cognitive Decline	Not applicable	Not yet open	2026-08	China
The Effect of Fu's Subcutaneous Needling on Skin Temperature in Healthy Subjects NCT07021924 · ClinicalTrials.gov ↗ · Skin Temperature Change	Not applicable	Not yet open	2025-07	China
2D Video Gait Analysis Platform Applying to AI Model for Adjustment of the Shoes' Sole NCT07003087 · ClinicalTrials.gov ↗ · Gait Disorders	Observational	By invitation	2024-08	China
Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital Therapy, to Digital Phenotyping and Biomarker Exploration NCT07222449 · ClinicalTrials.gov ↗ · Alzheimer Disease	Not applicable	By invitation	2026-05	China
Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites NCT05745233 · ClinicalTrials.gov ↗ · Malignant Ascites Drugs: Nivolumab, Pembrolizumab	Not applicable	By invitation	2021-01	China
The Effects of Knee Brace and Muscle Training on Osteoarthritis Patients NCT07246109 · ClinicalTrials.gov ↗ · Osteoarthritis (OA) of the Knee	Not applicable	By invitation	2025-03	China
The Effects of Kefir on Pediatric Obesity NCT06500104 · ClinicalTrials.gov ↗ · Obesity	Not applicable	By invitation	2024-07	China
Wearable-Based Study of Depression and Sleep in Older Adults NCT07232472 · ClinicalTrials.gov ↗ · Elderly Depression, Sleep Disturbance	Not applicable	By invitation	2026-04	China
0.01% and 0.025% Atropine Eye Drops Combined Auricular Acupoint Stimulation on Myopia Control and Corneal Endothelium Change NCT07537166 · ClinicalTrials.gov ↗ · Acupressure	Not applicable	By invitation	2026-04	China
Development of a Precision Nutrition Expert System Combining AI Dietary Image Recognition and Big Data Analysis: A Case Study on Kidney Disease NCT07829991 · ClinicalTrials.gov ↗ · Chronic Kidney Disease	Not applicable	Active, closed	2026-03	China
Local Injection Methylene Blue Combined With Radiation in HNSCC Patients NCT07435415 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Local Recurrent Tumor Drug: Methylene Blue	Phase EARLY_PHASE1	Active, closed	2025-08	China
Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment NCT07468422 · ClinicalTrials.gov ↗ · Cancer Patients With Solid Tumors, Cancer (Advanced Stage)	Observational	Active, closed	2025-10	China
The Effects of Astaxanthin on Physiological Anti-fatigue and Sports Performance: an Integrated Study From the Application of Laboratory Human Sports Platform to Simulated Competitions NCT07630870 · ClinicalTrials.gov ↗ · Healthy	Not applicable	Active, closed	2025-08	China
Enhancing Nursing Skills With SimCapture Technology NCT07143123 · ClinicalTrials.gov ↗ · Motivation, Clinical Skills Training, Nursing Students	Not applicable	Active, closed	2025-01	China
Timing of Damage Control Orthopedic Surgery NCT05785143 · ClinicalTrials.gov ↗ · The Precision Personal Timeline in Definitive Surgery Associated With Outcome	Observational	Active, closed	2022-07	China
Applying Interactive E-books on Breastfeeding to Enhance Nursing Students' Learning NCT07071285 · ClinicalTrials.gov ↗ · Nursing Education Research, Nursing Students, Breastfeeding Education	Not applicable	Active, closed	2025-09	China
An Initial Investigation Into the Effects of β-Alanine on Performance and Physiological Responses During Simulated Wrestling Matches NCT07641907 · ClinicalTrials.gov ↗ · Healthy, Athletes	Not applicable	Active, closed	2026-04	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in China Medical University Hospital trials

10 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Nmdae10 AIFA2 B10 L-BPA2 Alectinib1 Imatinib1 Methylene Blue1 Nivolumab1 Pembrolizumab1 Sertraline1 Trametinib1

Conditions in China Medical University Hospital trials

87 conditions

Schizophrenia7 Head and Neck Cancer2Primary Dysmenorrhea (PD)2Healthy2 Major Depressive Disorder2ADHD2Nursing Students2Connective Tissue Diseases1Interstitial Lung Disease1Boron Neutron Capture Therapy1Gait Disorders1Iron Deficiency1Iron Deficiency Anemias1Thyroidectomy1Alzheimer Disease1Thoracic Neoplasms1Healthy Aging1Digital Health Literacy1Chronic Kidney Disease1 Diabetic Kidney Disease1Local Recurrent Tumor1Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)1Unstable Sacral/Pelvic or Acetabular Fracture1Non-diabetic Chronic Kidney Disease1

By trial register

Register	Trials	Recruiting
Clinical trials in China	70	46

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Schizophrenia

Sponsor	Trials
Shanghai Mental Health Center	8
Bristol-Myers Squibb	7
Central South University	7
Neurocrine Biosciences	6
University of Pittsburgh	3
Vigonvita Life Sciences	3
Luye Pharma Group	3
Tianjin Anding Hospital	3
Vanda Pharmaceuticals	2
Karuna Therapeutics, Inc., a Bristol Myers Squibb company	2

Sponsors with the most current trials registered for this condition.

Questions about China Medical University Hospital trials

How many clinical trials does China Medical University Hospital sponsor?

China Medical University Hospital is the lead sponsor of 70 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are China Medical University Hospital trials recruiting?

Yes. 46 of its 70 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is China Medical University Hospital testing?

Its current trials name 10 drugs and biologicals as interventions. The most frequent are Nmdae (10), AIFA (2), B10 L-BPA (2), Alectinib (1) and Imatinib (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

China Medical University Hospital clinical trials